NAOMI WAAK: Open Payments
NPI 1083876072 · ATASCADERO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 36 payments from 11 companies in 2025. Trend: 2023 $941 · 2024 $719 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $227 |
| Radius Health, Inc. | 3 | $73 |
| GlaxoSmithKline, LLC. | 3 | $73 |
| Almatica Pharma LLC | 2 | $37 |
| PFIZER INC. | 2 | $36 |
| Amgen Inc. | 1 | $27 |
| ALK-Abello, Inc | 1 | $23 |
| Exact Sciences Corporation | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: UBRELVY, QULIPTA, Tymlos, TRELEGY ELLIPTA, VRAYLAR, LOREEV XR, NURTEC ODT, EVENITY.
Industry payments across CA — which companies pay providers there.
